Stopping seizure medications in adults with epilepsy
Part of Brain & nervous system clinical trials.
This study looks at what happens when people with epilepsy stop their seizure medications. The goal is to see if it's safe to stop after being seizure-free for a while, and to help patients and doctors make better decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have epilepsy and have been seizure-free for at least 2 years.
- You are currently taking at least one antiseizure medication.
- If you take only one medication, your risk of seizures returning after stopping must be 35% or less (calculated by a tool).
- You are not pregnant and do not plan to become pregnant during the study.
- You have not had epilepsy surgery and do not have a large brain lesion (like a tumor or major stroke).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.
This study looks at whether a special brain-recording procedure for difficult-to-control seizures changes a person’s memory, thinking, or other brain skills afterward. It may help doctors understand risks and plan care for people undergoing the procedure.
This study measures how much epilepsy medicine (lamotrigine, levetiracetam, or oxcarbazepine) your body absorbs during pregnancy and breastfeeding. It may help doctors better understand dosing and safety during these times.
This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.
This study looks at driving safety in people with epilepsy. It uses a driving simulator to understand how epilepsy affects driving ability.
This trial studies whether methylphenidate (a stimulant medicine) can improve thinking and memory problems related to epilepsy. You may be kept on your usual seizure medicines, and your thinking will be tested over about 16 weeks.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.